RESUMO
PURPOSE: The feasibility of early telerehabilitation after bariatric surgery is unknown. The objective of this study was to assess the feasibility and perception of engaging in the online exercise protocol in patients during the first month after bariatric surgery. MATERIAL AND METHODS: A total of 67 patients, enrolled in a telerehabilitation program following bariatric surgery, completed a survey assessing their perception of the intensity, discomfort, and safety during exercise sessions. RESULTS: Forty percent of participants began exercising between 5 and 10 days after surgery. Seventy-one percent of patients did not experience discomfort during the first month of exercise, and those who reported discomfort mainly mentioned dizziness and abdominal pain. No significant differences were found in the presence of discomfort among different types of surgeries performed. There was a significant difference in the presence of discomfort between patients who started exercising before and after 15 days of surgery, with less discomfort reported in the group that started after 15 days. Ninety-eight percent of patients felt safe during online exercise sessions. Most participants perceived the intensity of the sessions as moderate. The most frequently mentioned benefits of exercise were increased energy, mood, and feeling more active. CONCLUSION: Telerehabilitation conducted during the first month after bariatric surgery was feasible and well tolerated by patients, providing a safe alternative for those patients who face difficulties with in-person interventions.
Assuntos
Cirurgia Bariátrica , Terapia por Exercício , Estudos de Viabilidade , Obesidade Mórbida , Telerreabilitação , Humanos , Feminino , Masculino , Cirurgia Bariátrica/reabilitação , Adulto , Pessoa de Meia-Idade , Obesidade Mórbida/cirurgia , Obesidade Mórbida/psicologia , Terapia por Exercício/métodos , Inquéritos e Questionários , Satisfação do PacienteRESUMO
The Eltonian niche of a species is defined as its set of interactions with other taxa. How this set varies with biotic, abiotic and human influences is a core question of modern ecology. In seasonal environments, the realized Eltonian niche is likely to vary due to periodic changes in the occurrence and abundance of interaction partners and changes in species behavior and preferences. Also, human management decisions may leave strong imprints on species interactions. To compare the impact of seasonality to that of management effects, honeybees provide an excellent model system. Based on DNA traces of interaction partners archived in honey, we can infer honeybee interactions with floral resources and microbes in the surrounding habitats, their hives, and themselves. Here, we resolved seasonal and management-based impacts on honeybee interactions by sampling beehives repeatedly during the honey-storing period of honeybees in Finland. We then use a genome-skimming approach to identify the taxonomic contents of the DNA in the samples. To compare the effects of the season to the effects of location, management, and the colony itself in shaping honeybee interactions, we used joint species distribution modeling. We found that honeybee interactions with other taxa varied greatly among taxonomic and functional groups. Against a backdrop of wide variation in the interactions documented in the DNA content of honey from bees from different hives, regions, and beekeepers, the imprint of the season remained relatively small. Overall, a honey-based approach offers unique insights into seasonal variation in the identity and abundance of interaction partners among honeybees. During the summer, the availability and use of different interaction partners changed substantially, but hive- and taxon-specific patterns were largely idiosyncratic as modified by hive management. Thus, the beekeeper and colony identity are as important determinants of the honeybee's realized Eltonian niche as is seasonality.
RESUMO
Background: Patients with hereditary diffuse gastric cancer (HDGC) and germline mutations in the E-cadherin gene, CDH1, have a very high cumulative lifetime risk of developing diffuse gastric cancer. In these patients, it is formally recommended to perform a prophylactic total gastrectomy (PTG). Materials and Methods: We analyzed the course of patients with HDGC who have undergone PTG in our institution. Pedigree analysis, preoperative screening results, operative course, postoperative data, and complete stomach pathologic examination were performed in all patients. Results: Seven patients with confirmed CDH1 mutation underwent PTG, five were women, and average age was 27 years (range 17-42). Signet ring cell carcinoma was found in 1 patient in the preoperative surveillance endoscopic biopsies. Laparoscopic PTG was performed in all patients. There were two complications, an intestinal obstruction that required reintervention and an asymptomatic esophagojejunal anastomosis leak that resolved with conservative treatment. In all gastrectomy specimens, intramucosal signet ring cell carcinoma foci limited to the lamina propria were found (range 1-31), 83.5% were in the body-fundus region. The mean follow-up was 28.5 months (range 8-72). The mean weight loss was 9% (range 2-18). Postoperative symptoms associated with Dumping syndrome were the most frequent. All the patients reported of being very satisfied with the procedure and of having a better quality of life than expected before the procedure. Conclusion: Laparoscopic PTG is an excellent resource to prevent the development of advanced diffuse gastric cancer (DGC) in patients with HDGC with CDH1 mutation. The procedure was well tolerated with a high satisfaction rate and very good functional results. It should be considered in these patients due to the high risk of developing advanced DGC and the lack of effective and reliable surveillance studies.
Assuntos
Antígenos CD/genética , Caderinas/genética , Gastrectomia/métodos , Laparoscopia/métodos , Procedimentos Cirúrgicos Profiláticos/métodos , Neoplasias Gástricas/prevenção & controle , Adolescente , Adulto , Feminino , Predisposição Genética para Doença/genética , Mutação em Linhagem Germinativa , Humanos , Masculino , Linhagem , Estudos Retrospectivos , Neoplasias Gástricas/genética , Resultado do Tratamento , Adulto JovemRESUMO
INTRODUCTION: Myasthenia gravis is an antibody-mediated autoimmune disease. Approximately 10-15% of patients present with a thymoma, the presence of which is associated with greater severity of symptoms, myasthenic crisis, and irresponsiveness to front-line therapy. A thymectomy is recommended in young patients with generalized myasthenia gravis and in all patients presenting with thymoma. CLINICAL CASE: The patient was a 43-year-old woman, who first showed symptoms of myasthenic crisis in 2005 and presented with invasive thymoma managed with thymectomy and radiotherapy. In the subsequent three years, the patient presented with severe symptoms and two myasthenic crises that required mechanical ventilation and immunoglobulin treatment. Contrast chest computed tomography examinations showed no recurrence. Between 2009 and 2012, the patient experienced decreased symptom severity. In 2013, the patient presented with an exacerbation of symptoms; a contrast chest magnetic resonance scan showed a lesion in the anterior mediastinum, previously observed in 2011, suggestive of residual tissue as opposed to fibrosis. Regular management was started with immunoglobulins; a positron emission tomography scan was inconclusive, requiring a new resection, which showed no evidence of tumor recurrence. CONCLUSIONS: Patients with myasthenia gravis and those with myasthenia-related thymoma both share thymectomy as an element of treatment. However, following the procedure, exacerbation or reappearance of symptoms does not necessarily represent new alterations in the thymus.
Assuntos
Miastenia Gravis/etiologia , Complicações Pós-Operatórias/etiologia , Timectomia , Timoma/cirurgia , Neoplasias do Timo/cirurgia , Adulto , Terapia Combinada , Diagnóstico Diferencial , Progressão da Doença , Feminino , Humanos , Imageamento por Ressonância Magnética , Mediastino/diagnóstico por imagem , Miastenia Gravis/diagnóstico por imagem , Miastenia Gravis/tratamento farmacológico , Miastenia Gravis/cirurgia , Invasividade Neoplásica , Recidiva Local de Neoplasia/diagnóstico , Tomografia por Emissão de Pósitrons , Complicações Pós-Operatórias/diagnóstico por imagem , Complicações Pós-Operatórias/tratamento farmacológico , Complicações Pós-Operatórias/cirurgia , Timoma/patologia , Timoma/radioterapia , Neoplasias do Timo/patologia , Neoplasias do Timo/radioterapiaRESUMO
Mycobacterium tuberculosis (Mtb) infects different populations of macrophages. Alveolar macrophages (AMs) are initially infected, and their response may contribute to controlling Mtb infection and dissemination. However, Mtb infection may disseminate to other tissues, infecting a wide variety of macrophages. Given the difficulty in obtaining AMs, monocyte-derived macrophages (MDMs) are used to model macrophage-mycobacteria interactions in humans. However, the response of other tissue macrophages to Mtb infection has been poorly explored. We have compared MDMs, AMs and splenic human macrophages (SMs) for their in vitro capacity to control Mtb growth, cytokine production, and induction of cell death in response to Mtb H37Rv, and the Colombian isolate UT205, and to the virulence factor ESAT-6. Significant differences in the magnitude of cell death and cytokine production depending mainly on the Mtb strain were observed; however, no major differences in the mycobacteriostatic/mycobacteriocidal activity were detected among the macrophage populations. Infection with the clinical isolate UT205 was associated with an increased cell death with membrane damage, particularly in IFNγ-treated SMs and H37Rv induced a higher production of cytokines compared to UT205. These results are concordant with the interpretation of a differential response to Mtb infection mainly depending upon the strain of Mtb.
Assuntos
Macrófagos Alveolares/imunologia , Mycobacterium tuberculosis/imunologia , Tuberculose/imunologia , Adulto , Antígenos de Bactérias/metabolismo , Proteínas de Bactérias/metabolismo , Células Cultivadas , Ensaio de Imunoadsorção Enzimática , Feminino , Regulação da Expressão Gênica , Humanos , Interferon gama/metabolismo , Interleucina-18/metabolismo , Interleucina-1beta/metabolismo , Interleucina-6/metabolismo , Ativação de Macrófagos , Masculino , Fragmentos de Peptídeos/metabolismo , FagócitosRESUMO
Several genomes of different Mycobacterium tuberculosis isolates have been completely sequenced around the world. The genomic information obtained have shown higher diversity than originally thought and specific adaptations to different human populations. Within this work, we sequenced the genome of one Colombian M. tuberculosis virulent isolate. Genomic comparison against the reference genome of H37Rv and other strains showed multiple deletion and insertions that ranged between a few bases to thousands. Excluding PPE and PG-PGRS genes, 430 proteins present changes in at least 1 amino acid. Also, novel positions of the IS6110 mobile element were identified. This isolate is also characterized by a large genomic deletion of 3.6 kb, leading to the loss and modification of the dosR regulon genes, Rv1996 and Rv1997. To our knowledge, this is the first report of the genome sequence of a Latin American M. tuberculosis clinical isolate.
Assuntos
Proteínas de Bactérias/genética , Deleção de Genes , Genes Bacterianos , Genoma Bacteriano , Mycobacterium tuberculosis/genética , Proteínas Quinases/genética , Regulon , Tuberculose/microbiologia , Adulto , Colômbia , Proteínas de Ligação a DNA , Humanos , Masculino , Dados de Sequência Molecular , Mycobacterium tuberculosis/isolamento & purificação , Análise de Sequência de DNARESUMO
Introducción. La miastenia grave es una enfermedad autoinmunitaria mediada por anticuerpos. Entre 10 y 15 % de quienes la padecen tienen timoma y su presencia se asocia con una mayor gravedad de los síntomas, crisis miasténicas y fracaso del tratamiento de primera línea. La timectomía se recomienda en pacientes jóvenes con miastenia grave generalizada y en todos los pacientes con timoma. Caso clínico. Se presenta el caso de una mujer de 43 años que, en el 2005, presentó una primera crisis miasténica asociada con un timoma invasor que se trató con timectomía y radioterapia. Durante los siguientes tres años, presentó síntomas graves y dos crisis más, que obligaron a suministrarle respiración mecánica asistida e inmunoglobulina. Al cabo del tratamiento, no se evidenciaron signos de recurrencia en las tomografías de tórax con contraste. Entre el 2009 y el 2012, la gravedad de los síntomas fue menor. En el 2013, estos se exacerbaron y una resonancia magnética de tórax con contraste reveló una lesión en el mediastino anterior, ya observada en el 2011, sugestiva de tejido residual o fibrosis. Se inició el tratamiento usual con inmunoglobulina y se hizo una tomografía por emisión de positrones cuyos resultados no fueron concluyentes, por lo que se llevó a cabo una nueva resección y se constató que no había recurrencia del tumor. Conclusiones. Los pacientes con miastenia grave y aquellos con timoma asociado, deben someterse a la timectomía como parte del tratamiento. Sin embargo, la exacerbación de los síntomas o su reaparición después del procedimiento no necesariamente implica una nueva alteración en el timo.
Introduction: Myasthenia gravis is an antibody-mediated autoimmune disease. Approximately 10-15% of patients present with a thymoma, the presence of which is associated with greater severity of symptoms, myasthenic crisis, and irresponsiveness to front-line therapy. A thymectomy is recommended in young patients with generalized myasthenia gravis and in all patients presenting with thymoma. Clinical case: The patient was a 43-year-old woman, who first showed symptoms of myasthenic crisis in 2005 and presented with invasive thymoma managed with thymectomy and radiotherapy. In the subsequent three years, the patient presented with severe symptoms and two myasthenic crises that required mechanical ventilation and immunoglobulin treatment. Contrast chest computed tomography examinations showed no recurrence. Between 2009 and 2012, the patient experienced decreased symptom severity. In 2013, the patient presented with an exacerbation of symptoms; a contrast chest magnetic resonance scan showed a lesion in the anterior mediastinum, previously observed in 2011, suggestive of residual tissue as opposed to fibrosis. Regular management was started with immunoglobulins; a positron emission tomography scan was inconclusive, requiring a new resection, which showed no evidence of tumor recurrence. Conclusions: Patients with myasthenia gravis and those with myasthenia-related thymoma both share thymectomy as an element of treatment. However, following the procedure, exacerbation or reappearance of symptoms does not necessarily represent new alterations in the thymus.
Assuntos
Adulto , Feminino , Humanos , Complicações Pós-Operatórias/etiologia , Timectomia , Timoma/cirurgia , Neoplasias do Timo/cirurgia , Miastenia Gravis/etiologia , Complicações Pós-Operatórias/cirurgia , Complicações Pós-Operatórias/tratamento farmacológico , Complicações Pós-Operatórias/diagnóstico por imagem , Timoma/patologia , Timoma/radioterapia , Neoplasias do Timo/patologia , Neoplasias do Timo/radioterapia , Imageamento por Ressonância Magnética , Terapia Combinada , Progressão da Doença , Tomografia por Emissão de Pósitrons , Diagnóstico Diferencial , Mediastino/diagnóstico por imagem , Miastenia Gravis/cirurgia , Miastenia Gravis/tratamento farmacológico , Miastenia Gravis/diagnóstico por imagem , Invasividade Neoplásica , Recidiva Local de Neoplasia/diagnósticoRESUMO
A partir de la reflexión sobre la utilización despectiva de la retórica en la ciencia, en este ensayo se reseñan las principales formas de representación de los supuestos alcances de los fluoruros como medidas de salud pública. De manera crítica, se concluye que los discursos científicos, no exentos de la retórica, atribuyen a los fluoruros efectos que no tienen dentro de la misma lógica en que fueron construidos. Es, pues, una invitación a la recuperación de la retórica para el análisis de los problemas que aborda la ciencia, y de las políticas públicas que se han montado sobre diferentes discursos que representan estos problemas desde perspectivas evidentemente interesadas.
Departing from the analysis of the negative consideration of rethoric in the context of scientific discourse, this essay summarizes the main effects that fluoride has in the prevention of dental caries and in public health policies. It concludes that scientific discourses (immersed themselves in rethorical strategies) usually explain the effects of fluoride by using a logic that is not common to it. Thus, rethoric should still be used by scientific studies either when investigating the problems inherent to it or public policies based on non-independent perspectives.
Assuntos
Cárie Dentária , Conhecimento , Fluorose Dentária , FluoretaçãoRESUMO
La enfermedad coronaria es hoy en día la causa número uno de mortalidad en el mundo. Para los médicos es supremamente importante saber cómo enfrentarse a esta enfermedad de la mejor forma posible. El problema radica en que es mucha la información que se encuentra sobre el tema, pero esta no siempre es clara y frecuentemente es difícil de aplicar. Con esta revisión se pretende aclarar las herramientas adaptadas a la realidad de Colombia, con el fin de que el clínico sea capaz de abordar los pacientes comprendiendo el por qué de las acciones que toma. Se discutirán cuatro puntos críticos donde se cometen la mayoría de los errores: valoración de la probabilidad, estratificación del riesgo, interpretación del electrocardiograma y correcta utilización de los biomarcadores.
Coronary artery disease is today the number one cause of mortality worldwide. For doctors it is of the utmost importance to know the best possible way to approach these patients. The problem is that there is a lot of information on the subject and it is not always clear or easily applicable. This review intends to go over and explain the tools needed adapted to the Colombian reality, in order for the clinician to be able and engage these patients knowing the why of the actions taken. The four topics where most of the mistakes are made will be reviewed, these are: evaluation of the probability, risk stratification, electrocardiogram interpretation and correct use of biomarkers.